Diabetes Drugs Unexpectedly Raise Levels of Gut Microbe-Linked Heart Risk Marker TMAO
A pooled analysis of two placebo-controlled crossover trials shows that the SGLT-2 inhibitors empagliflozin and dapagliflozin modestly but significantly raise ...
A pooled analysis of two placebo-controlled crossover trials shows that the SGLT-2 inhibitors empagliflozin and dapagliflozin modestly but significantly raise ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine